AI platform identifies synergistic drug combination for resistant prostate cancer
A UCLA artificial intelligence platform paired with three-dimensional tumor testing identified berberine and enzalutamide as a synergistic combination in four ...
A UCLA artificial intelligence platform paired with three-dimensional tumor testing identified berberine and enzalutamide as a synergistic combination in four ...
Preclinical experiments found that erianin reduced prostate cancer cell activity and mouse tumor growth while lowering phosphorylation of the STAT3 ...
Immunohistochemical staining was positive in 48% of the 50 prostate cancer specimens and 18% of the 50 benign controls, a ...
A systematic review and meta-analysis of eight studies found elevated serum TK1 in prostate cancer and an association with higher ...
A laboratory study found that the urinary bacterium Actinobaculum massiliense can convert DHEA into testosterone, and molecular simulations from Auburn ...
A computational and laboratory study found that reducing HLTF diminished prostate cancer cell proliferation and suggested regulation of ZBP1-PANoptosome assembly ...
A laboratory study finds that the approved kinase inhibitor lapatinib can improve retention of a nanoparticle sonosensitizer in hypoxic prostate ...
A French early-access program of 3,709 patients with metastatic castration-resistant prostate cancer found that 177Lu-PSMA-617 produced efficacy and safety outcomes ...
A combined bulk and single-cell transcriptomic study identifies FLT3 and AIM2 among immune-associated genes in prostate cancer, while cell-line knockdown ...
A decade-long spatial panel study of US states finds prostate cancer incidence declining on average while PSA testing showed significant ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine